Plagens v. Deckard

CourtDistrict Court, N.D. Ohio
DecidedMay 9, 2024
Docket1:20-cv-02744
StatusUnknown

This text of Plagens v. Deckard (Plagens v. Deckard) is published on Counsel Stack Legal Research, covering District Court, N.D. Ohio primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Plagens v. Deckard, (N.D. Ohio 2024).

Opinion

UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF OHIO EASTERN DIVISION

WILLIAM PLAGENS, et al., ) Case No. 1:20-cv-2744 ) Plaintiffs, ) Judge J. Philip Calabrese ) v. ) ) JENNIFER D. DECKARD, et al., ) ) Defendant. ) )

ORDER GRANTING FINAL APPROVAL OF CLASS ACTION SETTLEMENT AND ASSOCIATED RELIEF Plaintiffs are former shareholders of Covia Holdings Corporation and/or its predecessor, Fairmount Santrol Holdings Inc. On December 10, 2020, Plaintiffs filed a class action complaint alleging that violations of federal securities law caused a significant drop in the share price of Covia stock and substantial losses to Plaintiffs. Following private mediation and negotiations, the parties reached a settlement, which the Court previously approved preliminarily. Plaintiffs move for final approval of the settlement and other associated relief. Following notice, no person filed any objection. On April 11, 2024, the Court held a hearing to determine the fairness, reasonableness, and adequacy of the settlement and took the motion under advisement. For the reasons that follow, the Court GRANTS Plaintiffs’ motion for final approval of the class action settlement, GRANTS IN PART and DENIES IN PART Plaintiffs’ motion for attorney’s fees, reimbursement of litigation expenses, and awards to Plaintiffs, and DISMISSES this case WITH PREJUDICE. FACTUAL AND PROCEDURAL BACKGROUND

Covia and its predecessor, Fairmont Santrol, sold sand-based proppants for use in fracking operations. (ECF No. 50, PageID #1066.) The market for proppants is exceedingly competitive, and the company marketed its products as premium products that would improve performance. (Id., PageID #1066–67.) Plaintiffs allege that company officers made false and misleading statements concerning the company’s products, and that the company’s own data contradicted the statements.

(Id., PageID #1067–68.) In March 2019, Covia received a subpoena from the SEC investigating Covia’s value-added proppants. (Id., PageID #1068.) Jenniffer Deckard resigned as the company’s chief executive officer soon after (id., PageID #1071), and on June 29, 2020, Covia declared bankruptcy (id., PageID #1070). After these events, the share price declined substantially, to $0.04 per share. (Id., PageID #1105.) In December 2020, Plaintiff William Plagens filed a complaint against Jenniffer D. Deckard, Mark E. Barrus, Michael F. Biehl, Andrew D. Eich, and

Richard A. Navarre, former officers of Covia and/or Fairmont Santrol. The complaint alleged violations of Sections 10(b) and 20(a) of the Exchange Act, 15 U.S.C. § 78j(b), and of Rule 10b-5. On January 29, 2021, Plaintiff Sergio Baron filed a nearly identical complaint against the same Defendants. (Baron, No. 1:21-cv-238, ECF No. 1, ¶¶ 17–21, PageID #4–5.) In an Order dated August 2, 2021, and pursuant to Rule 42(a), the Court consolidated Baron v. Deckard, No. 1:21-cv-238, into Plagens v. Deckard, No. 1:20-cv-2744. (ECF No. 42, PageID #879.) The settlement and this Order apply to both cases. Following a hearing, the Court appointed Dr. Thomas Phelps as lead Plaintiff

(Id., PageID #898.) Mr. Sergio Baron and Mr. Neville Arjani are also named Plaintiffs. (ECF No. 46, PageID #913.) In their corrected consolidated amended complaint, Plaintiffs allege that Defendants are liable for false or misleading statements that artificially inflated the value of their securities, in violation of Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934, 15 U.S.C. §§ 78j(b) and 78t(a), and Rule 10b-5, 17 C.F.R. § 240.10b-5. (ECF No. 50, ¶¶ 204–19,

Page ID #1119–1122.) Defendants moved to dismiss the complaint for failure to state a claim. (ECF No. 51.) On March 30, 2023, the Court issued an order granting in part and denying in part Defendants’ motion. (ECF No. 54.) The Court denied the motion to dismiss the claims for violations of Section 10(b) and Rule 10b-5, allowing them to proceed to discovery. (Id., PageID #2118.) Also, the Court dismissed Mr. Barrus, Mr. Biehl, Mr. Navarre, and Mr. Eich, leaving Ms. Deckard as the sole remaining Defendant.

(Id.) A. Discovery and Mediation The parties exchanged initial disclosures and engaged in extensive discovery, including responding to written discovery requests, review of the more than 22,000 pages of documents that Covia produced in response to a subpoena, depositions of confidential witnesses, and review of key documents from the SEC’s investigation such as its depositions of Ms. Deckard and other Covia employees and executives. (ECF No. 73, PageID #2396.) The parties undertook extensive settlement negotiations. They engaged

Robert A. Meyer of JAMS as a mediator. (Id.) A full-day mediation before Mr. Meyer did not result in a resolution, but the mediator continued to facilitate negotiations between the parties, culminating in the acceptance of a mediator’s proposal on September 11, 2023. (Id.) The settlement was memorialized by the execution of the Stipulation of Settlement, finalized on October 25, 2023. (Id.) B. Settlement On October 27, 2023, without opposition, Plaintiffs moved for preliminary

approval of the settlement. (ECF No. 71.) Under the settlement, Defendant agreed to pay a total sum of $6 million (ECF No. 71-2, ¶ 1.35, PageID #2306), consisting of several separate payments, in exchange for a release (Id., ¶ 2.1, PageID #2308). First, each Covia shareholder who is a member of the class and submits the proper forms to substantiate his or her claim will receive a pro rata share of the net settlement funds—the balance of the consideration for the settlement less the fees

and expenses discussed below. (Id., ¶ 8.2, PageID #2317.) Up to 10,195 class members will receive from the settlement fund (ECF No. 80-1, PageID #2715). That number reflects the total number of settlement class members who submitted claims. (Id.) Each authorized claimant will receive an amount based on a formula that determines the claimant’s recognized losses and calculates his or her pro rata share of the net settlement funds. (See ECF No. 79-1, PageID #2526–29.) In exchange for these payments, Plaintiffs release Defendant from all claims that were alleged or could have been alleged in this action. (ECF No. 71-2, ¶¶ 1.31 & 1.32, PageID #2305–06; id., ¶ 2.1, PageID #2308.) Second, Strategic Claims Services will receive compensation up to $500,000 for

its services in administering the settlement. (ECF No. 71-2, PageID #2309.) As the settlement administrator, SCS processed, printed, and mailed more than 37,000 copies of the notice of the settlement to potential class members and other relevant parties. (ECF No. 80-1, PageID #2713; ECF No. 79-1, PageID #2510–11.) SCS also notified more than 2,000 nominees, one of which advised that it emailed links to the notice and proof of claim to more than 19,000 of its clients. (ECF No. 80-1, PageID

#2713.) SCS published an electronic summary notice in an online newspaper and in print. (ECF No. 79-1, PageID #2514.) SCS continues to process claims, allowing claimants to cure any deficiencies in their claims, and will pay authorized claimants their pro rata share of the net settlement. (ECF No. 80-1, PageID #2715.) Third, the settlement seeks to reimburse Plaintiffs for their time and any expenses incurred in the representation of the class. (ECF No. 71-2, ¶ 8.2(c), PageID #2317.) Pursuant to the settlement, Lead Plaintiff Dr. Thomas Phelps seeks an

award of $10,000 (ECF No. 79-5, PageID #2562), as does Sergio Baron (ECF No.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Deposit Guaranty National Bank v. Roper
445 U.S. 326 (Supreme Court, 1980)
Amchem Products, Inc. v. Windsor
521 U.S. 591 (Supreme Court, 1997)
Wal-Mart Stores, Inc. v. Dukes
131 S. Ct. 2541 (Supreme Court, 2011)
In Re American Medical Systems, Inc. Pfizer, Inc.
75 F.3d 1069 (Sixth Circuit, 1996)
Comcast Corp. v. Behrend
133 S. Ct. 1426 (Supreme Court, 2013)
Gina Glazer v. Whirlpool Corporation
722 F.3d 838 (Sixth Circuit, 2013)
Beattie v. CenturyTel, Inc.
511 F.3d 554 (Sixth Circuit, 2007)
In Re AMF Bowling Securities Litigation
334 F. Supp. 2d 462 (S.D. New York, 2004)
Martha Dowling v. Litton Loan Servicing LP
320 F. App'x 442 (Sixth Circuit, 2009)
Shannon Van Horn v. Nationwide Property and Casualty
436 F. App'x 496 (Sixth Circuit, 2011)
Lakendus Cole v. City of Memphis
839 F.3d 530 (Sixth Circuit, 2016)
William Whitlock v. FSL Management
843 F.3d 1084 (Sixth Circuit, 2016)
Susan Hicks v. State Farm Fire & Casualty Co.
965 F.3d 452 (Sixth Circuit, 2020)
Young v. Nationwide Mutual Insurance
693 F.3d 532 (Sixth Circuit, 2012)
In re Cardizem CD Antitrust Litigation
218 F.R.D. 508 (E.D. Michigan, 2003)
Wilkof v. Carago Pharmaceutical Laboratories, Ltd.
280 F.R.D. 332 (E.D. Michigan, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
Plagens v. Deckard, Counsel Stack Legal Research, https://law.counselstack.com/opinion/plagens-v-deckard-ohnd-2024.